Publications
5443 Results
- Journal / Conference
- ASCO 6:137(#536)
- Year
- 1987
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8465
High-dose cisplatin (CDDP) for advanced sarcomas.
- Journal / Conference
- ASCO :#C-776
- Year
- 1987
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8503
ProMACE-CytaBOM is active with acceptable toxicity in patientswith unfavorable non-hodgkin's lymphomas: a groupwide Southwest OncologyGroup study.
- Journal / Conference
- ASH :#852
- Year
- 1987
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8508
MACOP-B chemotherapy for non-hodgkin's lymphomas: A SWOG Study.
- Journal / Conference
- ASCO :#C959
- Year
- 1987
- Research Committee(s)
- Genitourinary
Phase II clinical trial of IL-2/LAK in metastatic renal cancer.
- Journal / Conference
- ASCO 6:246(#970)
- Year
- 1987
- Research Committee(s)
- Melanoma
Phase II study of high dose interleukin-2 (IL-2) and lymphokineactivated killer (LAK) cells in patients (pts) with melanoma.
- Journal / Conference
- ASCO :#C-549
- Year
- 1987
Phase II trial of continuous infusion cytarabine (ARA-C) and bolus cis-platin (CDDP) in advanced solid tumors: renal, gastric, esophageal, pancreatic, and unknown primary cancers.
- Journal / Conference
- ASCO :#C-922
- Year
- 1987
Hepatitis a (HAV) infection occurring following IL-2/LAK cell therapy.
- Journal / Conference
- ASCO :#C-988
- Year
- 1987
Toxicity (TOX) of interleukin-2 and lymphokine-activated killer (LAK) cell therapy.
- Journal / Conference
- ASCO :#C-906
- Year
- 1987
Quality Control (QC) of the Community Clinical Oncology Program (CCOP) institutions within the Southwest Oncology Group (SWOG).
- Journal / Conference
- ASCO :#C-894
- Year
- 1987